Mike is a seasoned entrepreneur and executive who has dedicated his 30-year career to inventing, developing and commercializing medical device technologies to address unmet clinical needs. He is named on over 50 patents in US and International markets, which have resulted in multiple commercial products across various medical indications. Mike is the CEO of Endovascular Engineering, a clinical stage company developing mechanical thrombectomy solutions to address peripheral indications. Mike is also a Founder and General Partner of Inventure Group, a medical technology accelerator focused on bringing novel medical devices to market such as that being developed at E2, one of Inventure's portfolio companies. Mike previously was the COO of publicly-traded Entellus Medical [now a part of Stryker], a role he gained following the Entellus acquisition of Spirox Medical in 2017 where he spent five years leading R&D, operations, clinical and regulatory programs as COO and CTO. Prior to Spirox, Mike co-founded D3DC‚ a medical device incubator that invented, engineered and commercialized medical devices meeting clinical needs in ENT, Orthopedic, Cardiovascular, Structural Heart, and Plastics/Aesthetics. He spent a majority of his early career in executive research and development roles at FoxHollow Technologies [now a part of Medtronic] throughout its journey from start-up to a $1B market cap publicly-traded company. Mike received a Bachelor of Science in Mechanical Engineering from Stanford University where he was a member of the two-time NCAA champion varsity water polo team.
Mike is a seasoned entrepreneur and executive who has dedicated his 30-year career to inventing, developing and commercializing medical device technologies to address unmet clinical needs. He is named on over 50 patents in US and International markets, which have resulted in multiple commercial products across various medical indications. Mike is the CEO of Endovascular Engineering, a clinical stage company developing mechanical thrombectomy solutions to address peripheral indications. Mike is also a Founder and General Partner of Inventure Group, a medical technology accelerator focused on bringing novel medical devices to market such as that being developed at E2, one of Inventure's portfolio companies. Mike previously was the COO of publicly-traded Entellus Medical [now a part of Stryker], a role he gained following the Entellus acquisition of Spirox Medical in 2017 where he spent five years leading R&D, operations, clinical and regulatory programs as COO and CTO. Prior to Spirox, Mike co-founded D3DC‚ a medical device incubator that invented, engineered and commercialized medical devices meeting clinical needs in ENT, Orthopedic, Cardiovascular, Structural Heart, and Plastics/Aesthetics. He spent a majority of his early career in executive research and development roles at FoxHollow Technologies [now a part of Medtronic] throughout its journey from start-up to a $1B market cap publicly-traded company. Mike received a Bachelor of Science in Mechanical Engineering from Stanford University where he was a member of the two-time NCAA champion varsity water polo team.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy